Results From The Carmena Trial

Arnaud M éjean, MD, PhD, of the Hôpital Européen Georges Pompidou, discusses his study’s potentially practice-changing finding that nephrectomy is no longer the standard of care for patients with metastatic renal cell carcinoma (Abstract LBA3).08/08/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news